- Home
- ABEO vs CRNT Comparison
ABEO vs CRNT Comparison
Compare ABEO & CRNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- CRNT
- Stock Information
- Founded
- ABEO N/A
- CRNT 1996
- Country
- ABEO United States
- CRNT Israel
- Employees
- ABEO N/A
- CRNT N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- CRNT Radio And Television Broadcasting And Communications Equipment
- Sector
- ABEO Health Care
- CRNT Technology
- Exchange
- ABEO Nasdaq
- CRNT Nasdaq
- Market Cap
- ABEO 247.8M
- CRNT 207.3M
- IPO Year
- ABEO 1980
- CRNT 2000
- Fundamental
- Price
- ABEO $5.70
- CRNT $4.39
- Analyst Decision
- ABEO Strong Buy
- CRNT Strong Buy
- Analyst Count
- ABEO 3
- CRNT 4
- Target Price
- ABEO $18.00
- CRNT $6.44
- AVG Volume (30 Days)
- ABEO 229.2K
- CRNT 2.6M
- Earning Date
- ABEO 11-14-2024
- CRNT 02-18-2025
- Dividend Yield
- ABEO N/A
- CRNT N/A
- EPS Growth
- ABEO N/A
- CRNT N/A
- EPS
- ABEO N/A
- CRNT 0.21
- Revenue
- ABEO N/A
- CRNT $377,617,000.00
- Revenue This Year
- ABEO N/A
- CRNT $15.29
- Revenue Next Year
- ABEO $18,714.71
- CRNT $5.78
- P/E Ratio
- ABEO N/A
- CRNT $20.72
- Revenue Growth
- ABEO 147.52
- CRNT 13.62
- 52 Week Low
- ABEO $3.05
- CRNT $2.06
- 52 Week High
- ABEO $9.01
- CRNT $5.00
- Technical
- Relative Strength Index (RSI)
- ABEO 34.30
- CRNT 58.19
- Support Level
- ABEO $5.45
- CRNT $4.20
- Resistance Level
- ABEO $6.04
- CRNT $4.98
- Average True Range (ATR)
- ABEO 0.19
- CRNT 0.33
- MACD
- ABEO -0.04
- CRNT -0.08
- Stochastic Oscillator
- ABEO 19.47
- CRNT 29.07
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.
About CRNT Ceragon Networks Ltd.
Ceragon Networks Ltd is a wireless transport company in terms of unit shipments and global distribution of its business, providing high-capacity wireless connectivity solutions to global markets across various industries, mainly wireless (mobile) networks service providers. Geographically the company generates the major revenue from India. The company also has presence in North America, Europe, Africa, Asia-Pacific and Middle East, and Latin America. The company's products include IP-50 Platform, IP-20 Platform, Pointlink.